Showing 1,283 results

Filters Content type: News, Editors' picks Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

New & experimental HIV treatments

ViiV's newly minted HIV fighter Tivicay to cost $14K per year

Editor's pick
Fierce Pharma
14 August 2013
Access to healthcare

As US FDA approves promising new HIV drug dolutegravir, MSF asks when people in developing countries will have access

Editor's pick
MSF
13 August 2013
New & experimental HIV treatments

FDA approves new drug to treat HIV infection

Editor's pick
FDA
13 August 2013
Access to healthcare

HIV Survivors Seek Drug Advances as FDA Eases Approvals

Editor's pick
Bloomberg
12 August 2013
New & experimental HIV treatments

Fight AIDS with your smartphone

Editor's pick
CNN Money
8 August 2013
New & experimental HIV treatments

Plant-based compound may inhibit HIV

Editor's pick
Eurekalert Medicine & Health
30 July 2013
HIV treatment for children & young people

Low-Dose Drug Combo Safe in Kids with HIV

Editor's pick
Medpagetoday.com
8 July 2013
New & experimental HIV treatments

Long-acting GSK1265744 and TMC278-LA appear safe and practical in early study

News
5 July 2013
New & experimental HIV treatments

Dolutegravir superior to raltegravir for treatment-experienced people with HIV

News
4 July 2013
Changing treatment

Study supports WHO recommendations for second-line HIV therapy in resource-limited countries

News
4 July 2013
Resistance

Licensing agreement for development of diagnostic tests for HIV drug resistance

Editor's pick
University Hospitals Case Medical Center
3 July 2013
The search for a cure

Kick, kill, contain – researchers examine three possible steps in a cure for HIV

News
3 July 2013
HIV treatment for children & young people

New recommendations on HIV treatment for children require earlier diagnosis, new drug combinations for maximum impact

News
2 July 2013
Access to healthcare

2013 Pipeline Report calls on leaders to get the best HIV, hepatitis C virus (HCV), and tuberculosis drugs, diagnostics, and vaccines to the most people as quickly as possible

Editor's pick
Treatment Action Group
30 June 2013
New & experimental HIV treatments

Tenofovir Alafenamide Fumarate (TAF) Sign-On Letter to Gilead

Editor's pick
Treatment Action Group
17 June 2013
New & experimental HIV treatments

New FDA Guidance for Industry: Developing Antiretroviral Drugs for Treatment

Editor's pick
US Food and Drug Administration
11 June 2013
New & experimental HIV treatments

European Commission Approves Stribild®, a New Single Tablet Regimen for the Treatment of HIV-1 Infection

Editor's pick
Gilead press release
28 May 2013
New & experimental HIV treatments

Nanoparticles May Transport HIV Meds to the Brain

Editor's pick
AIDSMeds
16 May 2013
The search for a cure

UPDATE: Sangamo Highlights Encouraging Preliminary Anti-Viral HIV Data

Editor's pick
Benzinga
15 May 2013
New & experimental HIV treatments

Protease Inhibitors Boost Levels of Cenicriviroc, a CCR5/CCR2 Antagonist

Editor's pick
NATAP
14 May 2013
Pharmaceutical industry

Johnson & Johnson allies with biotech startup on HIV drug in China

Editor's pick
FierceBiotech
1 May 2013
New & experimental HIV treatments

FDA rejects two of the four drugs in Gilead's blockbuster HIV drug Stribild

Editor's pick
FierceBiotech
30 April 2013
The search for an HIV prevention vaccine

Researchers stop the only current HIV vaccine efficacy trial

News
26 April 2013
The search for a cure

Doctors' historic effort to cure child with HIV and leukemia

Editor's pick
MPR News
25 April 2013